Literature DB >> 11334506

From reactive arthritis to rheumatoid arthritis.

P Toivanen1.   

Abstract

Reactive arthritis was initially described as a sterile synovitis, without microbial components present in the joint tissue. It has, however, become evident that bacterial degradation products, and even bacterial DNA, are present in the synovium of patients with this disease. Since intestinal pathogens are important causes of reactive arthritis, and since cellular homing allows transport of bacterial products from the gut to synovium, we have approached the etiology of rheumatoid arthritis from this point of view. A series of observations has led to a hypothesis that patients with rheumatoid arthritis might favour, for genetic reasons, intestinal bacteria which are capable of inducing arthritis. In the long-run, with continuous seeding of bacterial products from the gut, the synovial inflammation is followed by erosion, exposition of cartilage antigens, and autoimmunity. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11334506     DOI: 10.1006/jaut.2000.0496

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  8 in total

Review 1.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Inflammatory 'double hit' model of temporomandibular joint disorder with elevated CCL2, CXCL9, CXCL10, RANTES and behavioural hypersensitivity in TNFR1/R2-/- mice.

Authors:  S L McIlwrath; R Nesemeier; F Ma; H S Oz; L Zhang; K N Westlund
Journal:  Eur J Pain       Date:  2017-03-20       Impact factor: 3.931

3.  The efficacy of probiotic supplementation in rheumatoid arthritis: a meta-analysis of randomized, controlled trials.

Authors:  Seyed Mohammad Aqaeinezhad Rudbane; Samane Rahmdel; Seyedeh Maryam Abdollahzadeh; Morteza Zare; Azam Bazrafshan; Seyed Mohammad Mazloomi
Journal:  Inflammopharmacology       Date:  2018-01-04       Impact factor: 4.473

4.  Enzyme degradation and proinflammatory activity in arthritogenic and nonarthritogenic Eubacterium aerofaciens cell walls.

Authors:  X Zhang; M Rimpiläinen; E Simelyte; P Toivanen
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis.

Authors:  J R Kirwan; R Hällgren; H Mielants; F Wollheim; E Bjorck; T Persson; C Book; S Bowman; M Byron; N Cox; M Field; L Kanerud; M Leirisalo-Repo; M Malaise; A Mohammad; R Palmer; I F Petersson; B Ringertz; P Sheldon; M Simonsson; N Snowden; F Van den Bosch
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

Review 6.  B cells in chronic obstructive pulmonary disease: moving to center stage.

Authors:  Francesca Polverino; Leen J M Seys; Ken R Bracke; Caroline A Owen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-08-19       Impact factor: 5.464

7.  Immunoglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthritis patients.

Authors:  Ketil Moen; Johan G Brun; Tor Magne Madland; Turid Tynning; Roland Jonsson
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

8.  Human Leukocyte Antigen-B27: The Genetic Predisposition Leading to Reactive Arthritis during Induction Phase Chemotherapy for Acute Myeloid Leukemia.

Authors:  Sandip P Bartakke; Abhilasha Ashok Sampagar; Vibha Sanjay Bafna; Putun Patel
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Jul-Sep
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.